Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020
Nia JulianMay 19, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing

Nia JulianMay 20, 2020
Next

Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets

Nia JulianMarch 9, 2020

© 2020 Solasta Ventures. All Rights Reserved.